Analisis Keuangan Saham ONCSQ - OncoSec Medical Incorporated (OTCPK) Stock

Gambaran Umum

OncoSec Medical Incorporated, based in the United States, operates within the biotechnology sector, principally engaged in the development of novel therapies for cancer treatment via immunotherapy. The company focuses on leveraging its proprietary technology, TAVO™ (tavokinogene telseplasmid), a plasmid DNA delivery formulation, utilized in conjunction with its electroporation delivery system to enhance the local and systemic effects of immunotherapy. A key project includes a clinical program assessing TAVO™ in combination with checkpoint inhibitors for treating metastatic melanoma, considered a particularly resistant cancer type to conventional therapies. OncoSec's strategy revolves around addressing the unmet medical needs in oncology, striving to provide innovative, efficacious treatments that can improve survival and quality of life for cancer patients.

Skor Kualitas, Nilai, dan Momentum

Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.

Kualitas

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Nilai

Model penilaian eksklusif yang memberi peringkat pada perusahaan berdasarkan valuasi relatifnya. Skor berkisar antara 0 hingga 100, dengan 100 sebagai yang paling diremehkan nilainya.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Sentimen Dana

Skor Sentimen Dana (sebelumnya dikenal sebagai Skor Kepemilikan) adalah model kuantitatif eksklusif yang memberi peringkat pada perusahaan berdasarkan tingkat akumulasi kepemilikan.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih

Nilai operating income untuk OncoSec Medical Incorporated per 2023 Jan 31 adalah -32.65 MM.
Nilai net income untuk OncoSec Medical Incorporated per 2023 Jan 31 adalah -29.39 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2023-01-31		-32.65	-29.39
2022-10-31		-34.40	-32.43
2022-07-31		-37.01	-34.18
2022-04-30		-40.96	-37.76
2022-01-31		-43.65	-40.95
2021-10-31		-46.26	-41.75
2021-07-31		-49.38	-45.17
2021-04-30		-45.71	-42.34
2021-01-31		-45.10	-42.79
2020-10-31		-46.61	-45.72
2020-07-31
2020-04-30

Laporan Laba Rugi: EPS

earnings per share basic untuk OncoSec Medical Incorporated pada 2023 Jan 31 adalah -14.77.
laba per saham yang terdilusi untuk OncoSec Medical Incorporated pada 2023 Jan 31 adalah -14.77.

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2023-01-31	-14.77	-14.77
2022-10-31	-18.13	-18.13
2022-07-31	-19.13
2022-04-30	-21.18	-21.18
2022-01-31	-23.30	-23.30
2021-10-31	-25.51	-25.51
2021-07-31	-30.20
2021-04-30	-32.24	-32.24
2021-01-31	-37.57	-37.57
2020-10-31	-48.91	-48.91
2020-07-31	-56.22
2020-04-30	-67.82	-67.82

Arus Kas: Operasi, Investasi, Pendanaan

Nilai cash from operating activities untuk OncoSec Medical Incorporated per 2023 Jan 31 adalah -24.99 MM.
Nilai cash from investing activities untuk OncoSec Medical Incorporated per 2023 Jan 31 adalah -0.01 MM.
Nilai kas dari aktivitas pendanaan untuk OncoSec Medical Incorporated per 2023 Jan 31 adalah 3.54 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2023-01-31	-24.99	-0.01	3.54
2022-10-31	-28.40	-0.24	-1.14
2022-07-31	-32.14	-0.24	-1.16
2022-04-30	-33.63	-0.29	-0.91
2022-01-31	-41.09	-0.79	6.83
2021-10-31	-41.92	-0.80	54.46
2021-07-31	-41.79	-0.80	68.21
2021-04-30	-42.75	-0.75	67.83
2021-01-31	-38.16	-0.25	89.51
2020-10-31	-34.75		41.84
2020-07-31
2020-04-30

Metrik Penilaian: PE, PriceToBook, PriceToTBV

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2023-01-31
2022-10-31
2022-07-31	-0.00	0.00	0.00
2022-04-30	-0.00	0.00	0.00
2022-01-31
2021-10-31	-0.00	0.00	0.00
2021-07-31	-0.00	0.00	0.00
2021-04-30
2021-01-31	-0.00	0.00	0.00
2020-10-31	-0.00	0.00	0.00
2020-07-31
2020-04-30

Metrik Penilaian: EBitToEv, EBit3YrAvgToEv

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2023-01-31
2022-10-31
2022-07-31	3.03	2.96
2022-04-30	2.30	2.21
2022-01-31
2021-10-31	1.20	1.02
2021-07-31	0.89	0.82
2021-04-30
2021-01-31	2.05	1.76
2020-10-31	2.28	1.98
2020-07-31
2020-04-30

Efektivitas Manajemen

roe untuk OncoSec Medical Incorporated pada 2023 Jan 31 adalah -1.48.

Period End (TTM)	ROA	ROE	ROIC (Tingkat Pengembalian Investasi Modal)	CROIC	OCROIC
2023-01-31		-1.48
2022-10-31		-1.13
2022-07-31	-0.59	-0.80	-1.54	-1.42	-1.37
2022-04-30	-0.59	-0.85	-1.28	-1.10	-1.29
2022-01-31		-0.85
2021-10-31	-1.51	-3.26	-0.90	0.51	-0.83
2021-07-31	-1.08	-1.95	-0.71	0.41	-0.72
2021-04-30		-1.95
2021-01-31	-1.97	-2.99	-1.89	0.29	-1.44
2020-10-31	-1.41	-1.74	-1.95	-0.22	-1.53
2020-07-31		-1.74
2020-04-30		-1.93

Gross Margins

Margin Kotor: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Margin Keuntungan Bersih: Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.

Margin Operasi: Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.

Period End (TTM)	Margin Kotor	Margin Keuntungan Bersih	Margin Operasi
2023-01-31
2022-10-31
2022-07-31
2022-04-30
2022-01-31
2021-10-31
2021-07-31
2021-04-30
2021-01-31
2020-10-31
2020-07-31
2020-04-30